Endoscopic Submucosal Dissection for Superficial Esophageal Neoplasms


  • Kouichi Nonaka Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan
  • Ryosuke Gushima Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan
  • Kouichi Sakurai Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan
  • Hiroto Kita Department of Gastroenterology, Saitama Medical University International Medical Center, Hidaka 350-1298, Japan
  • Yutaka Sasaki Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan




Endoscopic Submucosal Dissection (ESD), Superficial Esophageal Neoplasm (SCN), Narrow-band imaging (NBI), Steroid administration, Endoscopic ultrasonography (EUS)


Background and Aim: There has been a marked increase in the number of esophageal squamous cell neoplasms (SCNs) which are applicable to local treatment by virtue of recent developments in endoscopy. Endoscopic submucosal dissection (ESD) is an effective treatment for early noninvasive gastrointestinal cancers.

Aim of this study was to evaluate efficacy of ESD for superficial esophageal squamous cell neoplasms.

Subjects & Methods: Between November 2010 and March 2012, seventy-two lesions with superficial esophageal squamous cell neoplasms, which were treated by ESD in Kumamoto University Hospital, were analyzed in this study. Therapeutic efficacy, complications, and follow-up results were assessed.

Results: Mean size of the lesions was 19±14 mm (range; 1-80 mm); and mean size of the resection specimens was 29±13 mm (range; 7- 80mm). Extensive lesions over 2/3 of the circumference were observed in 17 patients. En bloc resection rate was 100% (72/72), and en block resection rate with tumor-free lateral/basal margins was 95.8% (69/72). Perforation didn’t occur. Endoscopic dilation was performed for post-operative stenosis in 10 patients. In 3 patients who developed pinhole-like stenosis followed by circumferential ESD, combination treatment of oral steroid administration with endoscopic dilation could achieve favorable courses. None of the patients developed local recurrence or distant metastasis in the follow-up period.

Conclusion: ESD is a minimally invasive, relatively safe treatment method for esophageal SCNs. In particular, it is suggested that ESD combined with oral steroid administration and endoscopic dilation, might be applicable to the patients with circumferential SCNs where post-operative stenosis must follow circumferential ESD.


Mandard AM, Tourneux J, Gignoux M, Blanc L, Segol P, Mandard JC. In situ carcinoma of the esophagus. Macroscopic study with particular reference to the Lugol test. Endoscopy 1980; 12: 51-7. http://dx.doi.org/10.1055/s-2007-1021710

Endo M, Takeshita K, Yoshida M. How can we diagnose the early stage of esophageal cancer? Endoscopic diagnosis. Endoscopy 1986; 18(Suppl 3): 11-8. http://dx.doi.org/10.1055/s-2007-1018435

Inoue H. [Endoscopic diagnosis of tissue atypism (EA) in the pharyngeal and esophageal squamous epithelium; IPCL pattern classification and ECA classification] . Kyobu Geka 2007; 60: 768-75.

Muto M, Minashi K, Yano T, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 2010; 28: 1566-72. http://dx.doi.org/10.1200/JCO.2009.25.4680

Tajima Y, Nakanishi Y, Ochiai A, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer 2000; 88: 1285-93. http://dx.doi.org/10.1002/(SICI)1097-0142(20000315)88:6<1285::AID-CNCR3>3.0.CO;2-R

Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol 2006; 19: 475-80. http://dx.doi.org/10.1038/modpathol.3800557

Nakajima Y, Nagai K, Miyake S, Ohashi K, Kawano T, Iwai T. Evaluation of an indicator for lymph node metastasis of esophageal squamous cell carcinoma invading the submucosal layer. Jpn J Cancer Res 2002; 93: 305-12. http://dx.doi.org/10.1111/j.1349-7006.2002.tb02173.x

Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer 2002; 94: 570-5. http://dx.doi.org/10.1002/cncr.10190

Chibana Y, Fujii S, Ichikawa K, et al. Tumor cell dissociation score highly correlates with lymph node metastasis in superficial esophageal carcinoma. J Gastroenterol Hepatol 2005; 20: 1371-8. http://dx.doi.org/10.1111/j.1440-1746.2005.03858.x

Makuuchi H. Endoscopic mucosal resection for mucosal cancer in the esophagus. Gastrointest Endosc Clin N Am 2001; 11: 445-58.

McCulloch P, Ward J, Tekkis PP. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 2003; 327: 1192-7. http://dx.doi.org/10.1136/bmj.327.7425.1192

Karl RC, Schreiber R, Boulware D, Baker S, Coppola D. Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy. Ann Surg 2000; 231: 635-43. http://dx.doi.org/10.1097/00000658-200005000-00003

Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc 2002; 56: 387-90. http://dx.doi.org/10.1016/S0016-5107(02)70043-6

Fujita H, Sueyoshi S, Yamana H, et al. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy. World J Surg 2001; 25: 424-31. http://dx.doi.org/10.1007/s002680020053

Katada C, Muto M, Manabe T, Ohtsu A, Yoshida S. Local recurrence of squamous-cell carcinoma of the esophagus after EMR. Gastrointest Endosc 2005; 61: 219-25. http://dx.doi.org/10.1016/S0016-5107(04)02756-7

Esaki M, Matsumoto T, Hirakawa K, et al. Risk factors for local recurrence of superficial esophageal cancer after treatment by endoscopic mucosal resection. Endoscopy 2007; 39: 41-5. http://dx.doi.org/10.1055/s-2006-945143

Ishihara R, Iishi H, Uedo N, et al. Comparison of EMR and endoscopic submucosal dissection for en bloc resection of early esophageal cancers in Japan. Gastrointest Endosc 2008; 68: 1066-72. http://dx.doi.org/10.1016/j.gie.2008.03.1114

Fujishiro M, Yahagi N, Kakushima N, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol 2006; 4: 688-94. http://dx.doi.org/10.1016/j.cgh.2006.03.024

Oyama T, Tomori A, Hotta K, et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol 2005; 3: S67-70. http://dx.doi.org/10.1016/S1542-3565(05)00291-0

Fujishiro M, Yahagi N, Kakushima N, et al. Successful nonsurgical management of perforation complicating endoscopic submucosal dissection of gastrointestinal epithelial neoplasms. Endoscopy 2006; 38: 1001-6. http://dx.doi.org/10.1055/s-2006-944775

Isomoto H, Yamaguchi N, Nakayama T, et al. Management of esophageal stricture after complete circular endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. BMC Gastroenterol 2011; 11: 46. http://dx.doi.org/10.1186/1471-230X-11-46




How to Cite

Kouichi Nonaka, Ryosuke Gushima, Kouichi Sakurai, Hiroto Kita, & Yutaka Sasaki. (2021). Endoscopic Submucosal Dissection for Superficial Esophageal Neoplasms. Journal of Analytical Oncology, 1(1), 67–73. https://doi.org/10.6000/1927-7229.2012.01.01.10